Collaboration Details

Print  Close


Title of Collaborative Activity:

Influenza Vaccine Manufacturing Improvement Group

Description of Collaborative Activity:

The Influenza Vaccine Manufacturing Improvement Group aims to optimize donor strains, improve sterility assays, and develop alternative potency assays.

Type of Collaborative Activity:

Committee, Advisory Group, or Work Group

Year the Collaborative Activity Originated:

2010

NIH Participating Institutes/Centers/Office of the Director:

NIAID

HHS Agency Collaborators on this Activity:

CDC, FDA, OS